179 related articles for article (PubMed ID: 38649513)
1. QbD Based Formulation Development and Optimisation of Ozenoxacin Topical Nano-Emulgel and Efficacy Evaluation Using Impetigo Mice Model.
Ramireddy AR; Behara DK
AAPS PharmSciTech; 2024 Apr; 25(5):90. PubMed ID: 38649513
[TBL] [Abstract][Full Text] [Related]
2. Formulation and optimisation of Ozenoxacin topical nano-emulgel including a comprehensive methodology to qualify and validate the critical parameters of an
Ramireddy AR; Behara DK
Drug Dev Ind Pharm; 2024 Apr; 50(4):320-330. PubMed ID: 38459688
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus.
Tarragó C; Esquirol LP; Arañó A; Lachamp L; D'Aniello F; Zsolt I
Future Microbiol; 2018 May; 13():21-30. PubMed ID: 29745240
[TBL] [Abstract][Full Text] [Related]
4. Systemic bioavailability and safety of twice-daily topical ozenoxacin 1% cream in adults and children with impetigo.
Gropper S; Cepero AL; Santos B; Kruger D
Future Microbiol; 2014; 9(8 Suppl):S33-40. PubMed ID: 25209523
[TBL] [Abstract][Full Text] [Related]
5. Ozenoxacin: a review of preclinical and clinical efficacy.
Vila J; Hebert AA; Torrelo A; López Y; Tato M; García-Castillo M; Cantón R
Expert Rev Anti Infect Ther; 2019 Mar; 17(3):159-168. PubMed ID: 30686133
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib-Loaded Topical Nano-Emulgel for Rheumatoid Arthritis: Formulation Design and Optimization by QbD, In Vitro, Ex Vivo, and In Vivo Evaluation.
Donthi MR; Saha RN; Singhvi G; Dubey SK
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986597
[TBL] [Abstract][Full Text] [Related]
7. Ozenoxacin: A Novel Topical Quinolone for Impetigo.
Wren C; Bell E; Eiland LS
Ann Pharmacother; 2018 Dec; 52(12):1233-1237. PubMed ID: 29962213
[TBL] [Abstract][Full Text] [Related]
8. Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.
Torrelo A; Grimalt R; Masramon X; Albareda López N; Zsolt I
Dermatology; 2020; 236(3):199-207. PubMed ID: 31958794
[TBL] [Abstract][Full Text] [Related]
9. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
[TBL] [Abstract][Full Text] [Related]
10. Ozenoxacin: A Novel Drug Discovery for the Treatment of Impetigo.
Sahu JK; Mishra AK
Curr Drug Discov Technol; 2019; 16(3):259-264. PubMed ID: 29732990
[TBL] [Abstract][Full Text] [Related]
11. Ozenoxacin 1% cream (Xepi) for impetigo.
Med Lett Drugs Ther; 2019 Apr; 61(1570):63-64. PubMed ID: 31169810
[No Abstract] [Full Text] [Related]
12. Topical drug delivery by Sepineo P600 emulgel: Relationship between rheology, physical stability, and formulation performance.
Badruddoza AZM; Zahid MI; Walsh T; Shah J; Gates D; Yeoh T; Nurunnabi M
Int J Pharm; 2024 Jun; 658():124210. PubMed ID: 38718972
[TBL] [Abstract][Full Text] [Related]
13. Development of Emulgel Delivery of Mupirocin for Treatment of Skin Infection.
Jagdale SC; Kothekar PV
Recent Pat Antiinfect Drug Discov; 2020; 15(2):137-156. PubMed ID: 32814540
[TBL] [Abstract][Full Text] [Related]
14. Nanosized nasal emulgel of resveratrol: preparation, optimization,
Salem HF; Kharshoum RM; Abou-Taleb HA; Naguib DM
Drug Dev Ind Pharm; 2019 Oct; 45(10):1624-1634. PubMed ID: 31353967
[TBL] [Abstract][Full Text] [Related]
15. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
16. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology.
Sinha P; Srivastava S; Mishra N; Singh DK; Luqman S; Chanda D; Yadav NP
Drug Dev Ind Pharm; 2016 Sep; 42(9):1434-45. PubMed ID: 26821208
[TBL] [Abstract][Full Text] [Related]
17. Delivery of adapalene using a novel topical gel based on tea tree oil nano-emulsion: Permeation, antibacterial and safety assessments.
Najafi-Taher R; Ghaemi B; Amani A
Eur J Pharm Sci; 2018 Jul; 120():142-151. PubMed ID: 29684425
[TBL] [Abstract][Full Text] [Related]
18. Systemic bioavailability, safety and tolerability of topical ozenoxacin in healthy adult volunteers.
Gropper S; Albareda N; Santos B; Febbraro S
Future Microbiol; 2014; 9(8 Suppl):S11-6. PubMed ID: 25209519
[TBL] [Abstract][Full Text] [Related]
19. Ozenoxacin (Xepi) for the Treatment of Impetigo.
Eudaley S
Am Fam Physician; 2020 Jun; 101(12):760-761. PubMed ID: 32538600
[No Abstract] [Full Text] [Related]
20. Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
Rosen T; Albareda N; Rosenberg N; Alonso FG; Roth S; Zsolt I; Hebert AA
JAMA Dermatol; 2018 Jul; 154(7):806-813. PubMed ID: 29898217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
